Investment Summary |
|
|---|---|
| Date | 2025-05-09 |
| Target | Ventro Group |
| Sector | Safety/Security |
| Investor(s) | KLAR Partners |
| Deal Type | Growth Capital |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 2020 |
| PE ASSETS | 1.5B USD |
| Size | Large |
| Type | Sector Agnostic |
KLAR Partners is a private equity firm focused on control investments in business services and industrial companies throughout Scandinavia, the Benelux, and the DACH regions of Europe. The Firm has a special interest in companies providing mission critical products and services, partnering with management to build sustainable, market-leading businesses through a responsible investment approach. KLAR Partners was formed in 2020 and has offices in Stockholm and London.
| DEAL STATS | # |
|---|---|
| Overall | 10 of 10 |
| Sector: Safety/Security M&A | 1 of 1 |
| Type: Growth Capital M&A Deals | 5 of 5 |
| Country: United Kingdom M&A | 1 of 1 |
| Year: 2025 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-06-05 |
Buhlmann Laboratories
Schonenbuch, Switzerland Bühlmann Laboratories is a manufacturer of specialty diagnostic tests and instruments for gastrointestinal inflammation, autoimmunity and allergy. Buhlmann Laboratories was founded in 1976 and is based in Schonenbuch, Switzerland. |
Buy | - |
